Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-5-9
pubmed:abstractText
Multistep carcinogenesis is exemplified by chronic myeloid leukemia with clinical manifestation consisting of a chronic phase and blast crisis. Pathological generation of BCR-ABL (breakpoint cluster region-Abelson) results in growth promotion, differentiation, resistance to apoptosis, and defect in DNA repair in targeted blood cells. Domains in BCR and ABL sequences work in concert to elicit a variety of leukemogenic signals including Ras, STAT5 (signal transducer and activator of transcription-5), Myc, cyclin D1, P13 (phosphatidylinositol 3-kinase), RIN1 (Ras interaction/interference), and activation of actin cytoskeleton. However, the mechanism of differentiation of transformed cells is poorly understood. A mutator phenotype of BCR-ABL could explain the transformation to blast crisis. The aim of this review is to integrate molecular and biological information on BCR, ABL, and BCR-ABL and to focus on how signaling from those molecules mirrors the biological phenotypes of chronic myeloid leukemia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0925-5710
pubmed:author
pubmed:issnType
Print
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
308-22
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:11345196-Animals, pubmed-meshheading:11345196-Blast Crisis, pubmed-meshheading:11345196-Cell Differentiation, pubmed-meshheading:11345196-Cell Transformation, Neoplastic, pubmed-meshheading:11345196-Disease Progression, pubmed-meshheading:11345196-Fusion Proteins, bcr-abl, pubmed-meshheading:11345196-Gene Expression Regulation, Leukemic, pubmed-meshheading:11345196-Genes, abl, pubmed-meshheading:11345196-Humans, pubmed-meshheading:11345196-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:11345196-Leukemia, Myeloid, Accelerated Phase, pubmed-meshheading:11345196-Leukemia, Myeloid, Chronic-Phase, pubmed-meshheading:11345196-Mice, pubmed-meshheading:11345196-Mice, Knockout, pubmed-meshheading:11345196-Models, Biological, pubmed-meshheading:11345196-Neoplasm Proteins, pubmed-meshheading:11345196-Neoplastic Stem Cells, pubmed-meshheading:11345196-Oncogene Proteins, pubmed-meshheading:11345196-Phenotype, pubmed-meshheading:11345196-Philadelphia Chromosome, pubmed-meshheading:11345196-Phosphorylation, pubmed-meshheading:11345196-Protein Processing, Post-Translational, pubmed-meshheading:11345196-Protein Structure, Tertiary, pubmed-meshheading:11345196-Protein-Tyrosine Kinases, pubmed-meshheading:11345196-Proto-Oncogene Proteins, pubmed-meshheading:11345196-Proto-Oncogene Proteins c-abl, pubmed-meshheading:11345196-Proto-Oncogene Proteins c-bcr, pubmed-meshheading:11345196-Rats, pubmed-meshheading:11345196-Signal Transduction, pubmed-meshheading:11345196-Structure-Activity Relationship
pubmed:year
2001
pubmed:articleTitle
Molecular biology of chronic myeloid leukemia.
pubmed:affiliation
Department of Genetics, Institute of Medical Science, University of Tokyo, Japan. ymaru@ims.u-tokyo.ac.jp
pubmed:publicationType
Journal Article, Review